Research Article
PILOT RANDOMIZED TRIAL OF A CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM FOR PATIENTS WITH MOOD DISORDERS
Article first published online: 17 OCT 2012
DOI: 10.1002/da.22003
© 2012 Wiley Periodicals, Inc.
Additional Information
How to Cite
Kilbourne, A. M., Li, D., Lai, Z., Waxmonsky, J. and Ketter, T. (2013), PILOT RANDOMIZED TRIAL OF A CROSS-DIAGNOSIS COLLABORATIVE CARE PROGRAM FOR PATIENTS WITH MOOD DISORDERS. Depress. Anxiety, 30: 116–122. doi: 10.1002/da.22003
Publication History
- Issue published online: 25 JAN 2013
- Article first published online: 17 OCT 2012
- Manuscript Accepted: 1 SEP 2012
- Manuscript Revised: 28 AUG 2012
- Manuscript Received: 15 JUN 2012
Funded by
- University of Michigan Comprehensive Depressive Center's Director's Innovation Award
- National Institutes of Mental Health. Grant Numbers: R01 MH79994, MH 74509
- Abstract
- Article
- References
- Cited By
Keywords:
- mood disorders;
- collaborative care;
- self-management
Objectives
Chronic care models improved outcomes for persons with mental disorders but to date have primarily been tested for single diagnoses (e.g. unipolar depression). We report findings from a pilot multisite randomized controlled trial of a cross-diagnosis care model for patients with mood disorders.
Methods
Patients (N = 60) seen in one of four primary care or mental health clinics affiliated with the National Network of Depression Centers were randomized to receive a mood disorder care model, Life Goals Collaborative Care (LGCC, N = 29) or usual care (N = 31). LGCC consisted of five group self-management sessions focused on mood symptom coping and health behavior change strategies followed by monthly patient and provider care management contacts for up to 6 months. Outcomes at 3 and 6 months included mood symptoms (Patient Health Questionnaire—PHQ-9, Internal State Scale—well-being, Generalized Anxiety Disorder scale) and health-related quality of life.
Results
Of the 60 enrolled, the mean age was 46.2 (SD = 13.2), 73.3% were female, 16.7% were non-white, and 36.8% had a bipolar disorder diagnosis. LGCC was associated with greater likelihood of depressive symptom remission in 6 months (respectively, 50% versus 19% had a PHQ-9 score ≤9 and 50% reduction in PHQ-9 score, P = .04) and improved well-being (β = 2.66, P ≤ .01, Cohen's D = 0.43).
Conclusions
LGCC may improve outcomes for patients regardless of mood diagnosis, potentially providing a feasible and generalizable chronic care model for routine practice settings.

1520-6394/asset/olbannerleft.gif?v=1&s=437dfd7be6907bc2789782afe68e506e19fae73a)
1520-6394/asset/olbannerright.gif?v=1&s=5df2fb724388d4331fe5f91b343d2546ccd6aa08)
